MedTrace Logo

Use of a Point-of-Care Platelet Function Assay for the Prediction of Atherothrombotic Events

NCT01183754 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2011-02-01

No results posted yet for this study

Summary

1. To evaluate the role of VerifyNow test as prognostic marker in routine clinical practice using drug-eluting stents.
2. To determine the add-on-effect of VerifyNow test beyond on conventional risk factors (clinical, lesions, or procedural factors).
3. To compare the prognostic utility of VerifyNow test with several biomarkers.

Conditions

Sponsors & Collaborators

  • CardioVascular Research Foundation, Korea

    lead OTHER

Principal Investigators

  • Seung-Jung Park, MD, PhD · Asan Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01183754 on ClinicalTrials.gov